Ronsheim Matthew insider trades
Ronsheim Matthew has filed 9 Form 4s with the SEC that we hold, for ETTX (Chief of Pharma Sciences & MFG) and Innoviva, Inc. (INVA) (See Remarks). Across all of them we count 0 purchases worth $0 and 1 sale worth $12.0K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 3,759 shares of ETTX worth $12.0K, dated 2021-10-19. The first filing on our record is dated 2021-10-20 and the latest 2024-05-21.
ETTX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-10-19 | S, sale reported on Form 4 | 3,759 | $12.0K | 2021-10-20 |
Innoviva, Inc. (INVA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1824386) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms